HealthSouth Slammed after Profit Warning
HealthSouth (HRC ) shares plummeted after the company said a July 1 change in Medicare and Medicaid reimbursement policy for outpatient services could cut its EBITDA by $175 million annually. The company suspended its EPS guidance. HealthSouth announced a number of executive changes in relation to its plans to effect a tax-free separation of the surgery center division into a public company. S&P downgraded the shares.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.